Integrative Medicine for Mental Health medicine and nutritional sciences referral and registry

ADHD
Tourette's Syndrome
Obsessive Compulsive Disorder
Anxiety
Depression
Mania
Panic
Bipolar Disorder
Schizophrenia
Eating Disorder
Anorexia Nervosa
Bulimia
Food Sensitivity
Title Author / Source Year Subject
Evidence that Increased Acetaminophen use in Genetically Vulnerable Children Appears to be a Major Cause of the Epidemics of Autism, Attention Deficit with Hyperactivity, and Asthma Shaw, William Ph.D 2013 Mental Disorders
Cholesterol Deficiency: A Major Factor in Many Chronic Disorders Shaw, William Ph.D - Mental Disorders
Lithium Deficiency: Common in Mental Illness and Social Ills Shaw, William Ph.D - Mental Disorders
Porphyrin Testing and Heavy Metal Toxicity: Unresolved Questions and Concerns Shaw, William Ph.D - Mental Disorders
Oxalates Control is a Major New Factor in Autism Therapy Shaw, William Ph.D - Mental Disorders
Candida and Overgrowth - The Problem & Bacteria By-products Shaw, William Ph.D - Mood Disorders
Associations between Acetaminophen Use during Pregnancy and ADHD Symptoms Measured at Ages 7 and 11 Years John M. D. Thompson, Karen E. Waldie mail, Clare R. Wall, Rinky Murphy, Edwin A. Mitchell, the ABC study group 2014 Mental Disorders
Don't Suffer with OCD Rebecca Shannonhouse 2013 Mental Disorders
Gut feelings: the future of psychiatry may be inside your stomach Carrie Arnold 2013 Mental Disorders
Usefulness of HPHPA marker in a wide range of neurological, gastrointestinal, and psychiatric disorders Shaw, William Ph.D 2010 Mental Disorders
The Role of Cholesterol in Autism Shaw, William Ph.D - Mental Disorders
The Unique Vulnerability of the Human Brain to Toxic Chemical Exposure and the Importance of Toxic Chemical Evaluation and Treatment in Orthomolecular Psychiatry Shaw, William Ph.D 2010 Mental Disorders
The Tomato Effect Greenblatt, James M.D. - Mental Disorders
National patterns in antidepressant medication treatment. Arch Gen Psychiatry, August, 2009 2009 Mental Disorders
Evaluation of outcomes with Citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. Madhukar, T., Am J Psychiatry. 2006; 163; 28-40 2006 Mental Disorders
Clinical features of treatment-resistant depression. Kornstein & Schneider. J Clin Psychiatry 2001 2001 Mental Disorders
The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression. DeBattista, C., et al., J Psychiatric Res, 2010 2010 Mental Disorders
Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Gesch, C.B., et al. (2002). British Journal of Psychiatry, 181, 22-28 2002 Mental Disorders
Science and society: Brain foods: the effects of nutrients on brain function Gómez-Pinilla, F. Nature Reviews Neuroscience 9, 568-578 (July 2008) 2008 Mental Disorders
Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Dolinoy, DC, D Huang and RL Jirtle. 2007. 2007 Mental Disorders
Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Dolinoy, et al., Environ Health Perspect, 2006 2006 Mental Disorders
Fooling Mother Nature: Epigenetics and novel treatments for psychiatric Disorders Stahl, S. (2010). CNS Spectrum, 15(4): 220-230 2010 Mental Disorders
Omeprazole therapy causes malabsorption of cyanocobalamin (Vitamin B12) Marcuard, S.P., et al. (1994). Ann Intern Med, 120:211-215 1994 Mental Disorders
What are the psychiatric manifestations of vitamin B12 deficiency? Hector M, Burton JR. J Am Geriatr Soc. 1988 1988 Mental Disorders
Vitamin B12 levels are low in hospitalized psychiatric patients. Silver H. Isr J Psychiatry Relat Sci, 2000 2000 Mental Disorders
Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from randomized, double-blind, placebo-controlled trial. Laan, et al., J Clin Psychiatry, 2010 2010 Mental Disorders
Rapid recovery from major depression using Magnesium treatment. Eby E, Eby K, Medical Hypotheses, 2006 2006 Mental Disorders
Is it time to trial vitamin D supplements for the prevention of schizophrenia? McGrath, Acta Psychiatr Scand, 2010 2010 Mental Disorders
Serum cholesterol levels and suicidal tendencies in psychiatric inpatients. Modai, et al., J Clin Psychiatry, 1994 1994 Mental Disorders
Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Amminger, et al., Arch Gen Psychiatry, 2010 2010 Mental Disorders
Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: relations with season, age, ethnic origin and psychiatric diagnosis. Humble, et al., J Steroid Biochem Mol Biol, 2010 2010 Mental Disorders
Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. Church, et al., J Neurol Neurosurg Psychiatry, 2003 2003 Mental Disorders
Identification of pyruvate kinase as an antigen associated with Tourette syndrome. Kansy, et al., J Neuroimmunol, 2006 2006 Mental Disorders
Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. Dale, et al., J Neuroimmunol, 2006 2006 Mental Disorders
A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Perlmutter, et al., Am J Psychiatry, 1998 1998 Mental Disorders
Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumonia, and beta-hemolytic streptococci). Gluck, et al., Am J Nutr, 2003 2003 Mental Disorders
Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features. Shaw, et al., Clin Chem, 1995 1995 Mental Disorders
Assessment of antifungal drug therapy in autism by measurement of suspected microbial metabolites in urine with gas chromatography-mass spectrometry. Shaw, et al., Clinical Practice of Alternative Medicine Magazine, 2000 2000 Mental Disorders
Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of clostridia spp. In the gastrointestinal tract, in urine samples from patients with autism and schizophrenia. Shaw W. Nutr Neurosci, 2010 2010 Mental Disorders
Short-term benefit from oral vancomycin treatment of regressive-onset autism. Sandler, et al., J Child Neurol, 2000 2000 Mental Disorders
Research suggests link between pesticides and brain disease. Gunderson D. Minnesota Public Radio, 2006 2006 Mental Disorders
Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease. Guillemin and Brew. Redox Rep, 2002 2002 Mental Disorders
Long-term occupational exposure and the diagnosis of dementia. Freed and Kandel. Neurotoxicology. 1988 1988 Mental Disorders
Solvent exposure as a risk factor for Alzheimer's disease: a case-control study. Kukull, et al., Am J Epidemiol, 1995 1995 Mental Disorders
Toxicant exposure and mental health-individual, social, and public health considerations. Genius SJ. J Forensic Sci, 2009 2009 Mental Disorders
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. Sas, et al., J Neurol Sci, 2007 2007 Mental Disorders
Cognitive decline as a manifestation of mitochondrial disorders (mitochondrial dementia). Finsterer J. J Neurol Sci, 2008 2008 Mental Disorders
The reaction of hyaluronic acid and its monomers, glucuronic acid and N-acetylglucosamine, with reactive oxygen species. Jahn, et al., Carbohydr Res, 1999 1999 Mental Disorders
Hyaluronidase and chondroitin sulphatase production by different species of Candida. Shimzu, et al., Medical Mycology, 1995 1995 Mental Disorders
Effectiveness of nystatin in polysymptomatic patients. A randomized, double-blind trial with nystatin versus placebo in general practice. Santelmann, et al., Fam Pract, 2001 2001 Mental Disorders
Function of dietary polyunsaturated fatty acids in the nervous system. Bourre, et al., Prostaglandins Leukot Essent Fatty Acids, 1993 1993 Mental Disorders
Natural Products in the Clinical Treatment of Mental Illness: A Profile of Dr. James Greenblatt, M.D. Leonard, Joe - Mental Disorders
ADHD Greenblatt, James M.D. - Mental Disorders
Nutritional Supplements in ADHD Greeblatt, James M.D., Letter to the Editor of J Am Acad Child Adolesc Psychiatry, 38:10, October 1999 1999 Mental Disorders
Nutritional Treatment for Attention Deficit Hyperactivity Disorder: The Hype and the Hope - A Review of Current Research Greenblatt, James M.D. and Gina L. Nick, Ph.D., N.D. - Mental Disorders
Oligomeric Proanthocyanidins as an Alternative Treatment for ADHD: A Case Study Greenblatt, James M.D. - Mental Disorders
Pycnogenol for ADHD? Steven W. Heimann, M.D., Letter to the Editor of J Am Acad Child Adolesc Psychiatry, 38:4, April 1999 1999 Mental Disorders
The Complete Assessment for Attention Deficit Hyperactivity Disorder Greenblatt, James M.D. - Mental Disorders
Low Cholesterol and Its Psychological Effects Greenblatt, James M.D., The Breakthrough Depression Solution, June 10, 2011 2010 Mood Disorders
The Depressing News About Antidepressants (PDF) Begley, S., Newsweek, February 8, 2010 2010 Mood Disorders
Rapid recovery from major depression using Magnesium treatment. Eby E, Eby K, Medical Hypotheses, 2006 2006 Mood Disorders
Vitamin B12 deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging Study. Penninx, et al., Am J Psychiatry 2000 2000 Mood Disorders
The utility of laboratory screening in medically ill patients with psychiatric symptoms Catalano, et al., Annals of Clinical Psychiatry, 2001 2001 Mood Disorders
A routine CBC leads to a non-routine diagnosis Middleman and Melchiono, Adolesc Med, 1996 1996 Mood Disorders
A case of mania secondary to vitamin B12 deficiency Goggans, American Journal of Psychiatry, 1984 1984 Mood Disorders
T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression Huang and Lee, Psychiatry Clin Neurosci, 2007 2007 Mood Disorders
Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy Sutcigil, et al., Clin Dev Immunol, 2007 2007 Mood Disorders
The effects of tryptophan depletion on mood and psychiatric symptoms Van der Does, Journal of Affective Disorders, 2001 2001 Mood Disorders
Dietary tyrosine benefits cognitive and psychomotor performance during body cooling O'Brien, et al., Physiology & Behavior, 2007 2007 Mood Disorders
Enhancement of the antidepressant action of fluoxetine by folic acid: a randomized, placebo controlled trial Coppen and Bailey, Journal of Affective Disorders, 2000 2000 Mood Disorders
Folate, vitamin B12, and homocysteine in major depressive disorder Fava, et al., Am J Psychiatry, 1997 1997 Mood Disorders
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression. Papakostas, et al., J Clin Psychiatry, 2004 2004 Mood Disorders
Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. Gilbody, et al. J Epidemiol Community Health, 2007 2007 Mood Disorders
Folic acid and the treatment of depression. Abou-Saleh & Copper, J Psychosom Res, 2006 2006 Mood Disorders
Folate and colorectal cancer: an evidence-based critical review. Kim, Mol Nutr Food Res, 2007 2007 Mood Disorders
Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Morris, et al., Arch Neurol, 2005 2005 Mood Disorders
Serum homocysteine levels and cognitive functioning in euthymic bipolar patients. Dias, et al., J Affective Disorders, 2009 2009 Mood Disorders
S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. Papakostas, et al., Am J Psychiatry, 2010 2010 Mood Disorders
Zinc: the new antidepressant? Levenson, Nutr Rev, 2006 2006 Mood Disorders
Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Nowak, Pol J Pharmacol, 2003 2003 Mood Disorders
Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. Siwek, et al., J Affect Disord, 2009 2009 Mood Disorders
Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer's disease and Down syndrome. Jang, et al., Proc Natl Acad Sci USA, 2010 2010 Mood Disorders
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Stoll, et al., Arch Gen Psychiatry, 1999 1999 Mood Disorders
Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. Clayton, et al., Eur J Clin Nutr, 2009 2009 Mood Disorders
Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial. Behzadi, et al., Acta Psychiatr Scand, 2009 2009 Mood Disorders
Successful treatment of bipolar disorder II and ADHD with micronutrient formula: a case study. Rucklidge and Harrison, CNS Spectr, 2010 2010 Mood Disorders
Effect of lithium maintenance on suicidal behavior in major mood disorders. Tondo, et al., Ann NY Acad Sci, 1997 1997 Mood Disorders
Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation. Basselin, et al., J Lipid Res, 2010 2010 Mood Disorders
Low serum cholesterol in suicide attempters. Kunugi, et al., Biol Psychiatry, 1997 1997 Mood Disorders
Association of low serum total cholesterol with major depression and suicide. Partonen, et al., Br J Psychiatry, 1999 1999 Mood Disorders
Low serum cholesterol and external-cause mortality: potential implications for research and surveillance. Boscarino, et al., J Psychiatr Res, 2009 2009 Mood Disorders
Low serum HDL-cholesterol levels are associated with long symptom duration in patients with major depressive disorder. Lehto, et al., Psychiatry Clin Neurosci, 2010 2010 Mood Disorders
Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Nemets, et al., Am J Psychiatry, 2006 2006 Mood Disorders
Omega-3 fatty acids in major depressive disorder: A preliminary double-blind, placebo-controlled trial. Su, et al., Eur Neuropsychoparmacol, 2003 2003 Mood Disorders
Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial. Rondanelli, et al., J Am Coll Nutr, 2010 2010 Mood Disorders
Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Sublette, et al., Am J Psychiatry, 2006 2006 Mood Disorders
Depression and serum adiponectin and adipose omega-3 and omega-6 fatty acids in adolescents. Mamalakis, et al., Pharmacol Biochem Behav, 2006 2006 Mood Disorders
Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. Clayton, et al., Eur J Clin Nutr, 2009 2009 Mood Disorders
Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Zanarini, et al., Am J Psychiatry, 2003 2003 Mood Disorders
Blood lead levels and major depressive disorder, panic disorder, and generalized anxiety disorder in US young adults. Bouchard, et al., Arch Gen Psychiatry, 2009 2009 Mood Disorders
The role of catecholamines, 5-hydroxytryptamine and m-tyramine in the behavioural effects of m-tyrosine in the rat. Dyck, et al., Eur J Pharmacol, 1982 1982 Mood Disorders
Chronic intestinal candidiasis as a possible etiological factor in the chronic fatigue syndrome. Cater RE, Med Hypotheses, 1995 1995 Mood Disorders
Increased number of Candida albicans in the faecal microflora of chronic fatigue syndrome patients during the acute phase of illness. Evengard, et al., Scan J Gastroenerol, 2007 2007 Mood Disorders
Differential effects of cholesterol and 7-dehydrocholesterol on ligand binding of solubilized hippocampal serotonin1A receptors: implications in SLOS. Chattopadhyay, et al., Biochem Biophys Res Commun, 2007 2007 Mood Disorders
Seasonal genetic influence on serum 25-hydroxyvitamin D levels: a twin study. Snellman, et al., PLoS One, 2009 2009 Mood Disorders
Association between low plasma levels of cholesterol and relapse in cocaine addicts. Buydens-Branchey L, Branchey M. Psychosom Med, 2003 2003 Mood Disorders
Omega-3 fatty acids in major depressive disorder Freeman MP. J Clin Psychiatry, 2009 2009 Mood Disorders
The efficacy of omega-3 supplementation for major depression: a randomized controlled trial Lesperance, et al., J Clin Psychiatry, 2010 2010 Mood Disorders
Beyond the Basics – New Approaches to Treatment of Anorexia Nervosa Greenblatt, James M.D., Chief Medical Officer, Walden Behavioral Care - Eating Disorders
Clinical Treatment of Anorexia Nervosa Merits More Attention Greenblatt, James M.D., Chief Medical Officer, Walden Behavioral Care - Eating Disorders
Excess mortality, causes of death and prognostic factors in anorexia nervosa. Papadopoulos, et al., Br J Psychiatry, 2009 2009 Eating Disorders
Three psychotherapies for anorexia nervosa: a randomized, controlled trial. McIntosh, et al., Am J Psychiatry, 2005 2005 Eating Disorders
A retrospective study of SSRI treatment in adolescent anorexia nervosa: insufficient evidence for efficacy. Holtkamp, et al., J Psychiatr Res, 2005 2005 Eating Disorders
Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. Walsh, et al., JAMA, 2006 2006 Eating Disorders
Puberty moderates genetic influence on disordered eating. Klump, et al., Psychol Med, 2007 2007 Eating Disorders
Zinc deficiency in anorexia nervosa. Katz, et al., J Adolesc Health Care, 1987 1987 Eating Disorders
Oral zinc supplementation in anorexia nervosa. Safai-Kutti, Acta Psychiatr Scand Suppl, 1990 1990 Eating Disorders
Zinc status before and after zinc supplementation of eating disorder patients. McClain, et al., J Am Coll Nutr, 1992 1992 Eating Disorders
Zinc deficiency and childhood-onset anorexia nervosa. Lask, et al., J Clin Psychiatry, 1993 1993 Eating Disorders
Controlled trial of zinc supplementation in anorexia nervosa. Birmingham, et al., Int J Eat Disord. 1994 1994 Eating Disorders
Anorexia nervosa responding to zinc supplementation: a case report. Yamaguchi, et al., Gastroenterol Jpn, 1992 1992 Eating Disorders
A pilot open case series of ethyl-EPA supplementation in the treatment of anorexia nervosa. Ayton, et al., Prostaglandins Leukot Essent Fatty Acids, 2004 2004 Eating Disorders
Eating disorders: hope despite mortal risk. Kaye, W. Am J Psychiatry, 2009 2009 Eating Disorders
A peptide found in schizophrenia and autism causes behavioral changes in rats. Sun, et al., Autism, 1999 1999 Mental Disorders
Urinary peptide levels in women with eating disorders. A pilot study. Hellzen, et al., Eat Weight Disord, 2003 2003 Eating Disorders
Double-blind, controlled trial of Inositol treatment of depression. Levine, et al., Am J Psychiatry, 1995 1995 Eating Disorders
Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Benjamin, et al., Am J Psychiatry, 1995 1995 Eating Disorders
Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. Palatnik, et al., J Clin Psychopharmacol, 2001 2001 Eating Disorders
Inositol treatment of obsessive-compulsive disorder. Fux, et al., Am J Psychiatry, 1996 1996 Eating Disorders
Effect of Inositol on bulimia nervosa and binge eating. Gelber, et al., Int J Eat Disord, 2001 2001 Eating Disorders
Neurochemical individuality: genetic diversity among human dopamine and serotonin receptors and transporters. Cravchik A, Golman D. Arch Gen Psychiatry, 2000 2000 Eating Disorders
A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate the clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder. Koetter, et al., Phytother Res, 2007 2007 Sleep Disorders
Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal? Poyares, et al., Prog Neuropsychopharmacol Biol Psychiatry, 2002 2002 Sleep Disorders
Niacinamide's potent role in alleviating anxiety with its benzodiazepine-like properties: a case report. Prousky, JE, Orthomol Med, 2004 2004 Sleep Disorders
The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD). Positive response to magnesium oral loading test. Starobrat-Hermelin B, Kozielec T, Magnes Res, 1997 1997 Sleep Disorders
Reasons to Perform Total IgG Food Allergy Testing Instead of IgG4 Food Allergy Testing. Shaw, William Ph.D - Food Allergies
New insight into the solution structures of wheat gluten proteins from Raman optical activity. Blanch, et al., Biochemistry, 2003 2003 Food Allergies
Intestinal digestive resistance of immunodominant gliadin peptides. Hausch, et al., Am J Physiol Gastrointest Liver Physiol, 2002 2002 Food Allergies
Advances in celiac disease and gluten-free diet. Niewinski NM, J AM Diet Assoc, 2008 2008 Food Allergies
Gluten sensitivity as a neurological illness. Hadjivassiliou, et al., J Neurol Neurosurg Psychiatry, 2002 2002 Food Allergies
Frontal cortical perfusion abnormalities related to gluten intake and associated autoimmune disease in adult celiac disease: 99m Tc-ECD brain SPECT study. Usai, et al., Dig Liver Dis, 2004 2004 Food Allergies
Depression in adult untreated celiac subjects: diagnosis by the pediatrician. Corvaglia, et al., Am J Gastroenterol, 1999 1999 Food Allergies
Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs. Maes, et al., Acta Psychiatr Scand, 1996 1996 Food Allergies
Lower activity of serum peptidases in abstinent alcohol-dependant patients. Maes, et al., Alcohol, 1999 1999 Food Allergies
Dipeptidyl peptidase IV and adenosine deaminase activity. Decrease in depression. Elgun, et al., Psychoneuroendocrinology, 1999 1999 Food Allergies
Autism and Schizophrenia: Intestinal Disorders Cade, et al., Nutritional Neuroscience, 2000 2000 Food Allergies
Beta-casomorphin induces fos-like immunoreactivity in discrete brain regions relevant to schizophrenia and autism. Sun, et al., Autism, 1999 1999 Food Allergies
Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Jyonouchi, et al., Neuropsychobiology, 2002 2002 Food Allergies
Gliadin stimulates human monocytes to production of IL-8 and TNF-alpha through a mechanism involving NF-kappaB. Jelinkova, et al., FEBS Lett, 2004 2004 Food Allergies
Critical analysis of the diets of chronic juvenile offenders. Schauss, et al., J Orthomolecular Psychiatry, 1979 1979 Food Allergies
Higher plasma concentration of food-specific antibodies in persons with autistic disorder in comparison to their siblings. Trajkovski, et al., Focus on Autism, 2008 2008 Food Allergies
Food allergy and infantile autism. Lucarelli, et al., Panminerva Med, 1995 1995 Food Allergies
Neuropsychological dysfunction related to earlier occupational exposure to mercury vapor. Zachi, et al., Braz J Med Biol Res, 2007 2007 Toxic Chemicals
Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults. Calderon-Garciduenas, et al., Toxicol Pathol, 2008 2008 Toxic Chemicals
An anthropological approach to the evaluation of preschool children exposed to pesticides in Mexico. Guillette, et al., Environ Health Perspect, 1998 1998 Toxic Chemicals
Medications as a source of human exposure to phthalates. Hauser, et al., Environ Health Perspect, 2004 2004 Toxic Chemicals
Origins of and Recognition of Micronutrient Deficiencies After Gastric Bypass Surgery Bal BS, et al., Curr Diab Rep., 2010 2010 Other
Dr. Greenblatt's Interview with Latitudes - - Other
Functional Psychiatry Greenblatt, James M.D. - Other
Ten Warning Signs of Good Health - - Other